Trial Profile
Imatinib pharmacokinetics in a large observational cohort of gastrointestinal stromal tumor patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2016
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Pharmacokinetics
- 20 Jan 2016 New trial record